News | October 21, 2022
Cadila Pharma's Esiloc wins "Best Launch of the Year"
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
The award recognizes Parexel for delivering the best decentralized trial experience for customers through its capabilities, expertise, and patient recruitment and retention strategies
None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable
MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism resulting in toxic sulfite levels causing neurologic sequelae
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
In Q2 FY23, the overall performance of the company continued to be strong despite the ongoing geo-political challenges impacting supply chain and costs
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Yoshindo gets exclusive commercialization rights in Japan for bUstekinumab and bDenosumab developed and manufactured by Biocon Biologics
The hospital has taken a huge step by offering “Titli-palliative care services at home” to provide curative, restorative, and life-prolonging treatment to seriously ill children
Subscribe To Our Newsletter & Stay Updated
